To achieve this objective, treatment of DM has been continually enriched by several novel therapeutic approaches such that, currently, there is a wide therapeutic arsenal that has increased with the incorporation of insulin analogues [12–14] and the activators of the incretin effect [15–17]. The gene discussed is INS; the disease is diabetes mellitus.